Tablets found aboard an ancient shipwreck could identify the early beginnings of medicine. A team of scientists led by Erika Ribechini of the University of Pisa (Pisa, Italy) determined the composition of tablets found aboard a ship-wrecked off the coast of Tuscany (Italy) around 2,000 years ago.1
Tablets found aboard an ancient shipwreck could identify the early beginnings of medicine.
A team of scientists led by Erika Ribechini of the University of Pisa (Pisa, Italy) determined the composition of tablets found aboard a ship-wrecked off the coast of Tuscany (Italy) around 2,000 years ago.1
Analysis of the inorganic compounds was performed using energy dispersion (SEM-EDX) and fourier transform infrared spectroscopy (FTIR); and analysis of the organic compounds was performed using an analytical procedure based on gas chromatography–mass spectrometry (GC–MS).GC–MS analysis showed that the tablets contained a mixture of vegetal and animal fats, plant pollens and beeswax. One of the most abundant classes of compounds was zinc hydrocarbonate and zinc carbonate, still used widely in modern medicine formulations. The authors speculate that the tablets were used as eye medication, potentially an eyewash.
According to co‑author and colleague Giachi Gianna, Soprintendenza per i Beni Archeologici della Toscana (Florence, Italy), ancient medicines are rarely found, and so it is very unusual for their chemical composition to be published. The majority of the information available on these medicines is known solely from the writings of ancient authors.
The tablets were originally discovered in 1990, but it was only recently that scientists chose to update the investigation. Medical equipment was found aboard the ship indicating that a physician would have been travelling as part of the crew when the ship was wrecked. Amongst the artifacts were 136 wooden vials, a stone mortarium, a cupping bronze, an iron probe and a number of tin pyxies (small boxes used to hold medicines).
The regular discoid-shaped tablets were found within one of the tin pyxies. The lack of oxygen within the container combined with a tight seal formed by the degradation products of the tin pyxis had created an unusual preservative environment.
Gianna told The Column that the authors hope to compare the composition of the tablets with other medicines in the future.
Reference
Gianna Giachi et al, PNAS DOI: 10.1073/pnas.1216776110 (2013).
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.